Our objectives were : ( 1 ) to determine bioequivalence of paclitaxel pharmaceutically formulated as LEP-ETU ( test ) and paclitaxel formulated with castor oil ( reference ) ; and ( 2 ) to assess the tolerability of LEP-ETU following intravenous administration .